0

Journal Articles

in Diabetes Mellitus Type 2
 161-180 of 265 Articles
From the Centers for Disease Control and Prevention |  FREE
JAMA. 2005;293(4):416-420. doi:10.1001/jama.293.4.419.

Clinical Review |  FREE
Nalini Singh, MD; David G. Armstrong, DPM, MSc, PhD; Benjamin A. Lipsky, MD
JAMA. 2005;293(2):217-228. doi:10.1001/jama.293.2.217.
INCLUDES: CME

Health Agencies Update | 
JAMA. 2004;292(24):2963. doi:10.1001/jama.292.24.2963-b.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2004;292(22):2715-2718. doi:10.1001/jama.292.22.2715.

Brief Report |  FREE
Caroline S. Fox, MD, MPH; Sean Coady, MA; Paul D. Sorlie, PhD; et al.
JAMA. 2004;292(20):2495-2499. doi:10.1001/jama.292.20.2495.

Original Contribution |  FREE
George L. Bakris, MD; Vivian Fonseca, MD; Richard E. Katholi, MD; et al.
JAMA. 2004;292(18):2227-2236. doi:10.1001/jama.292.18.2227.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2004;292(18):2206-2210. doi:10.1001/jama.292.18.2208.

Original Contribution |  FREE
Russell L. Rothman, MD, MPP; Darren A. DeWalt, MD, MPH; Robb Malone, PharmD, CDE; et al.
JAMA. 2004;292(14):1711-1716. doi:10.1001/jama.292.14.1711.

Original Contribution |  FREE
Amy R. Weinstein, MD, MPH; Howard D. Sesso, ScD, MPH; I. Min Lee, MBBS, ScD; et al.
JAMA. 2004;292(10):1188-1194. doi:10.1001/jama.292.10.1188.

Editorial | 
Caroline M. Apovian, MD
JAMA. 2004;292(8):978-979. doi:10.1001/jama.292.8.978.

Original Contribution |  FREE
Matthias B. Schulze, DrPH; JoAnn E. Manson, MD; David S. Ludwig, MD; et al.
JAMA. 2004;292(8):927-934. doi:10.1001/jama.292.8.927.

The World in Medicine | 
JAMA. 2004;291(21):2534. doi:10.1001/jama.291.21.2534-c.

Medical News and Perspectives | 
JAMA. 2004;291(20):2419-2420. doi:10.1001/jama.291.20.2419.

Original Contribution |  FREE
James B. Meigs, MD, MPH; Frank B. Hu, MD, PhD; Nader Rifai, PhD; et al.
JAMA. 2004;291(16):1978-1986. doi:10.1001/jama.291.16.1978.

Original Contribution |  FREE
Jaakko Tuomilehto, MD, PhD; Gang Hu, MD, PhD; Siamak Bidel, MD; et al.
JAMA. 2004;291(10):1213-1219. doi:10.1001/jama.291.10.1213.

Medical News and Perspectives | 
JAMA. 2004;291(9):1056-1057. doi:10.1001/jama.291.9.1056.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2004;291(8):935-937. doi:10.1001/jama.291.8.935.

Medical News and Perspectives | 
JAMA. 2004;291(7):809-810. doi:10.1001/jama.291.7.809.

Original Contribution |  FREE
Rui Jiang, MD, DrPH; JoAnn E. Manson, MD, DrPH; James B. Meigs, MD, MPH; et al.
JAMA. 2004;291(6):711-717. doi:10.1001/jama.291.6.711.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2004;291(5):555-556. doi:10.1001/jama.291.5.555.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Correction  | 
Error in Table in: Communication and Medication Refill Adherence: The Diabetes Study of Northern California

JAMA Internal Medicine
Viewpoint  | 
Nullius In Verba:  Don't Take Anyone's Word for It
Richard S. Lehman, MA, BM,  BCh, MRCGP
JAMA Internal Medicine
Original Investigation  | 
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Internal Medicine
Invited Commentary  | 
Glucagonlike Peptide 1–Based Drugs and Pancreatitis:  Clarity at Last, but What About Pancreatic Cancer?
Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus”
Belinda Gier, PhD; Peter C. Butler, MD